Wijma, Allard G.
Eisenga, Michele F.
Nijkamp, Maarten W.
Hoogwater, Frederik J. H.
Klaase, Joost M.
Article History
Received: 16 January 2023
Accepted: 30 June 2023
First Online: 11 July 2023
Declarations
:
: The study protocol was approved by the Medical Ethics Committee of the UMCG, the Netherlands (Netherlands research registration number 201800293). This study was performed in accordance with the ethical standards set by the Declaration of Helsinki. All patients provided written consent before being included in the study.
: Written informed consent for publication of their clinical details and/or clinical images was obtained from the patients. A copy of the consent form is available for review by the Editor of this journal.
: MFE has declared receiving consultant fees from Vifor Pharma and Cablon Medical; serving on the Advisory Board for Cablon Medical and GlaxoSmithKline; and receiving speaker fees from Vifor Pharma, Pharmacosmos, and Astellas.